Actavis Said to Begin Bond Offering For Allergan Deal

Actavis Plc started marketing bonds in a nine-part offering to finance its purchase of Botox-maker Allergan Inc., according to a person with knowledge of the transaction.

The drug company, which said last month it plans to sell as much as $22 billion in what would be the biggest offering since Verizon Communications Inc.’s record offering in 2013, will sell the bonds as soon as Tuesday, said the person, who asked not to be identified without authorization to speak publicly.

(Corrects spelling of Verizon Communications in second paragraph.)
Before it's here, it's on the Bloomberg Terminal.